Items where authors include "Etherington, C."

Article

Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Gillgrass, L., Caley, L.R. orcid.org/0000-0001-8957-1018 et al. (6 more authors) (2024) Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del. PLOS ONE, 19 (5). e0304555. ISSN 1932-6203

Tachtatzis, P., Spoletini, G. orcid.org/0000-0002-5462-0083, Clifton, I. orcid.org/0000-0002-9758-9506 et al. (2 more authors) (2024) Changes in liver biochemistry and tacrolimus levels following the introduction of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and liver transplant. Journal of Cystic Fibrosis, 23 (1). pp. 99-102. ISSN 1569-1993

Spoletini, G. orcid.org/0000-0002-5462-0083, Watson, R., Lim, W.Y. et al. (4 more authors) (2021) Nasal high-flow therapy as an adjunct to exercise in patients with cystic fibrosis: A pilot feasibility trial. Journal of Cystic Fibrosis, 20 (5). e46-e52. ISSN 1569-1993

Spoletini, G. orcid.org/0000-0002-5462-0083, Pollard, K., Watson, R. et al. (6 more authors) (2021) Noninvasive Ventilation in Cystic Fibrosis: Clinical Indications and Outcomes in a Large UK Adult Cystic Fibrosis Center. Respiratory Care, 66 (3). pp. 466-474. ISSN 0020-1324

Proceedings Paper

Tachtatzis, P., Spoletini, G., Etherington, C. et al. (2 more authors) (2022) OP31 Can liver biopsy guide the management of deranged liver function tests in liver transplant recipients receiving Kaftrio? In: Gut. British Association for the Study of the Liver Annual Meeting, 20–23 September 2022, 20-23 Sep 2022, Leeds, United Kingdom. BMJ Publishing Group , A27-A28.